investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
Ritu Aneja
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Emad Rakha
University of Nottingham
Nottingham, United Kingdom
Ritu Aneja
Georgia State University
Atlanta, United States
Related projects
Philip Tofilon
Radiation-induced translational control of gene expression
Breast
Radiation Oncology
Mark I Greene
Carbohydrate Antigenic Biomarkers for Epithelial Cancers
Breast
Pierre-Alexandre Vidi
Interplay Between Tissue Architecture and Nuclear Organization in the DNA Damage
Breast
Dana Pe'Er
Integrative Cancer Genomics: Drivers, Pathways and Drugs
Breast
David H Haussler
Center for Big Data in Translational Genomics
Breast
Bing Xia
Targeting Autophagy in Hereditary Breast Cancer
Breast
Bert W O'Malley
Reproductive Hormones - Biological and Molecular Actions
Breast
Christopher H Contag
Dynamic Imaging of EMT in the Breast Cancer Microenvironment
Breast
Mara A Schonberg
Breast Cancer Risk Factors Among Women Aged 75 and Older
Breast